Back
Regeneron Pharmaceuticals
REGN
$784.85
-0.58%
Overview
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company's commercialized medicines...
Open
$0.00
Prior close
$789.45
Today's high
$0.00
Today's low
$0.00
52 Week high
$859.34
52 Week low
$541.00
News
The Motley Fool • 3 days ago • REGN
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
MarketBeat • 4 days ago • REGN
Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum
Seeking Alpha • 4 days ago • REGN
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
